MCM
CALA

Mazama Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Mazama Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-184
Closed -$28K – 199
2015
Q4 		$28K Hold
184
– – 0.01% 238
2015
Q3 		$20K Buy
+184
New +$23.8K ﹤0.01% 249

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Mazama Capital Management's CALA Position: Q1 2016 in Review

Mazama Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2016, closing a stake of 184 shares — an estimated $28K sold.

Mazama Capital Management first reported a position in CALA in Q3 2015 and held it in 2 quarters. The position peaked at $28K in Q4 2015. 52 funds tracked by Wall St. Rank hold CALA as of Q1 2016.

  • Mazama Capital Management reported no remaining Calithera Biosciences, Inc position as of Q1 2016 after selling out during the quarter.
  • Mazama Capital Management sold 184 Calithera Biosciences, Inc shares in Q1 2016, an estimated $28K.
  • Mazama Capital Management first reported a position in Calithera Biosciences, Inc in Q3 2015 and held it in 2 quarters.
  • Mazama Capital Management's Calithera Biosciences, Inc position peaked at $28K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.